Mirae Asset Global Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.8K Sell
1,972
-394
-17% -$7.95K ﹤0.01% 1393
2026
Q1
$46.4K Buy
2,366
+133
+6% +$3.25K ﹤0.01% 1308
2025
Q4
$59.8K Buy
2,233
+435
+24% +$11.2K ﹤0.01% 1358
2025
Q3
$47.9K Sell
1,798
-23
-1% -$594 ﹤0.01% 1349
2025
Q2
$41.8K Buy
1,821
+212
+13% +$5.26K ﹤0.01% 1289
2025
Q1
$45.7K Buy
1,609
+7
+0.4% +$224 ﹤0.01% 1256
2024
Q4
$60.6K Sell
1,602
-159
-9% -$7.27K ﹤0.01% 1241
2024
Q3
$84.6K Buy
1,761
+301
+21% +$13.2K ﹤0.01% 1216
2024
Q2
$58.9K Sell
1,460
-16,460
-92% -$682K ﹤0.01% 1215
2024
Q1
$688K Sell
17,920
-509
-3% -$26.3K ﹤0.01% 1738
2023
Q4
$1.14M Buy
18,429
+48
+0.3% +$2.52K ﹤0.01% 1552
2023
Q3
$845K Buy
18,381
+57
+0.3% +$3.11K ﹤0.01% 1605
2023
Q2
$1.05M Buy
18,324
+640
+4% +$28.4K ﹤0.01% 1530
2023
Q1
$663K Sell
17,684
-31
-0.2% -$1.02K ﹤0.01% 1785
2022
Q4
$496K Buy
17,715
+488
+3% +$14.2K ﹤0.01% 1897
2022
Q3
$484K Buy
17,227
+4,908
+40% +$160K ﹤0.01% 1885
2022
Q2
$428K Buy
+12,319
New +$440K ﹤0.01% 1827

Other funds holding AMPH

Mirae Asset Global Investments's AMPH Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Amphastar Pharmaceuticals (AMPH) stake by 17% in Q2 2026, selling an estimated $7.95K and leaving 1,972 shares worth $39.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1393.

Mirae Asset Global Investments first reported a position in AMPH in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.14M in Q4 2023. 82 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Mirae Asset Global Investments held 1,972 shares of Amphastar Pharmaceuticals worth $39.8K as of Q2 2026.
  • Mirae Asset Global Investments sold 394 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $7.95K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1393 holding.
  • Mirae Asset Global Investments first reported a position in Amphastar Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Amphastar Pharmaceuticals position peaked at $1.14M in Q4 2023.
  • 82 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.